So the changes that the private equity firms make, it sounds like they really affect quality of life for these physicians.
That's right. A lot of these trends can have very real, very human implications on job satisfaction, work-life balance, whether you see career progression, long-term in medicine and so on. And those are questions that are harder to study systematically.
Some recent work I've done has shown that PE investments of physician practices in particular are followed by physicians quitting the practice and oftentimes moving to different regions in search of alternate employment. A recent study of mine showed that physician turnover increases by about 200% when PE firms buy up a practice.
It sounds like they kind of start to feel just sort of like a cog in the system instead of like an independent doctor making the right choices for their patients.
That's exactly right. I talk to a lot of physicians for my work, just, you know, to understand what their experience is like and one doctor described it to me as being a professional athlete. They said, you're just being traded from one team to the other and you're being told how to, you know, practice and how to be a professional by people who have no idea. And you have no say in who you get sold to. You have no say in who you get traded to. And that's just what the practice of medicine has become.
And most people didn't go to medical school for that.
Absolutely not.
How are patients seeing these changes? How is it affecting them?
So there's some early research that shows when PE firms invest in nursing homes and hospitals, patient care really deteriorates in the nursing home setting.
Mortality goes up by about 10% in the hospital setting. There's an increase in infections and falls and worse patient care experiences, based on how patients themselves self-report their care experience. It's a little harder to study in the setting of physician practices because as you can imagine, you know, a lot of the settings where PE firms are investing like ophthalmology practices, for example. Care is pretty standard. It's really difficult to see the complexity after a cataract surgery, for example. And so those settings are not as well studied as hospitals and nursing homes. But overall, the prognosis isn't great.
One of the clearest changes though, is just about the cost of health care:
The research literature is pretty consistent that when PE firms invest in health care, the cost of care goes up. We often don't see any clear benefits materialized to patients or health care workers.
You know, we might not always see the harms, but the fact that the cost of care goes up and quality doesn't change at best, means that the value of care goes down. And so to me, you know, that signals a broader problem in the sustainability of this approach.